Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Hospitals

 

Minority stake in $2bn Metro Pacific could put IPO back on the table

Investment firm Metro Pacific Investments Corp (MPIC) is reportedly preparing to sell a minority stake in its hospital business, the largest in the Philippines, in a deal that would value the company at $2bn or 15.8x 2019 expected EBITDA. HBI sources speculate that it could be the run-up to an IPO.
June 20, 2019

Private sector penetration of dialysis compared across EMEA

The latest addition to our Intelligence Centre, dialysis, is the only healthcare sector that has been successfully industrialised, internationalised and privatised by over half, across the EMEA markets we look at. There are four global haemodialysis (the bulk of dialysis) service operators, Fresenius Medical Care, B Braun, Diaverum and Davita (in order of geographical reach). But on the third measure, privatisation, the story is a varied one as shown in this week's infographic.
June 20, 2019

Medsi triples public work, targets IPO

Russian private healthcare operator Medsi tripled its work with the public payor in Q1 2018, growing revenues by half and nearly doubling margins. We talk owner Sistema about expanding Medsi outside of Moscow, and its IPO plans.
June 20, 2019

Indian hospitals building fewer beds

India's hospitals have all but stopped building beds in Tier I cities in the past two years, instead investing in smaller cities. HBI explores new bed growth data. 
June 20, 2019

Medlife has money to spend in CEE

Listed Romanian healthcare group Medlife says it has €20m to spend on new acquisitions in Romania and Hungary. Although it and for-sale competitor Regina Maria have both completed large domestic deals in the past month, the internationalisation effort probably highlights that most good assets in Romania have now been bought.
June 13, 2019

Hirslanden hospital closure looms as tariff and Canton reforms bite

Mediclinic-owned Swiss hospital group Hirslanden looks set to close a 28-bed hospital unless "alternative proposals" can be found, blaming tariff changes and moves by the local Canton. It is less than 1% of Hirslanden's sales but is the first casualty of the tariff reforms amongst the hospital market's big players. We talk to the CEOs of both Mediclinic International and Hirslanden about the closure and the Swiss market generally.
June 13, 2019
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us